1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports training in infectious disease epidemiology to develop innovative and independent investigators in the field.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Academic institutions. Confirm the full requirements in the official notice before applying.
Epidemiology of Infectious Diseases is funded by NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Notice of Award of a Single Source Cooperative Agreement To Fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces five separate awards to fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. For Institute of Epidemiology, Disease Control and Research, Bangladesh, the award is for approximately $1,000,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For National Institute of Public Health, Cambodia, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Madagascar, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For National Health Laboratory Service, South Africa, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For L. Sakvarelidze National Center for Disease Control and Public Health, Georgia, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 funding amount for the five recipients is $4,600,000. Funding amounts for years 2-5 for each recipient will be set at continuation The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-07. Federal Register document number: 2026-16110.
Epidemiological Studies of Vaccination and Health Outcomes Across the Lifespan is sponsored by National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID). This NIH highlighted topic encourages investigator-initiated research into the comprehensive evaluation of the relationships between vaccines and long-term health outcomes across the lifespan.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article